Natus Medical Inc. buy melinda
Startpreis
30.11.18
/
50%
32,18 €
Kursziel
17.12.18
33,37 €
Rendite (%)
-10,87 %
Endpreis
17.12.18
28,68 €
Zusammenfassung
Diese Einschätzung wurde am 17.12.18 mit einem Endkurs von 28,68 € beendet. Mit einer Rendite von -10,87 % entwickelte sich die Einschätzung BUY nicht nach Plan. melinda hat 50% Zuversicht bei dieser Einschätzung
Finanztrends
Rendite ohne Dividenden (%)
Name | 1W | 1M | 1J | 3J |
---|---|---|---|---|
Natus Medical Inc. | - | - | - | - |
iShares Core DAX® | 1,20 % | 2,11 % | 17,17 % | 16,92 % |
iShares Nasdaq 100 | 3,22 % | -1,38 % | 22,80 % | 33,74 % |
iShares Nikkei 225® | 1,86 % | 0,89 % | 10,06 % | -0,68 % |
iShares S&P 500 | 2,17 % | 0,61 % | 22,74 % | 38,27 % |
Kommentare von melinda zu dieser Einschätzung
In der Diskussion Natus Medical Inc. diskutieren
SecteurEquipement et technologie médicale avancés Agenda 13/12 | 17:00 Assemblée générale
Manufactures medical devices
Natus Medical, Inc. engages in the provision of newborn care, neurology, and hearing and balance assessment healthcare products and services.
Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.
Natus Medical, Inc. engages in the provision of newborn care, neurology, and hearing and balance assessment healthcare products and services.
Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.
Nombre d'employés : 1 726 personnes.
(Vom Mitglied beendet)
Beendete Einschätzungen von melinda zu Natus Medical Inc.
Natus Medical Inc.
Startkurs
Kursziel
Rendite (%)
14,80 €
29.08.20
29.08.20
17,00 €
04.11.21
04.11.21
54,05 %
05.11.21
05.11.21